[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)
date : 4/2/2024
Tags: AMR
![[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20240304_AMR_01-scaled-1.jpg)
On March 4 and 5, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the Joint Japan/ UK Science and Policy Workshop which was held in Shinjuku-ku, Tokyo, Japan.
The Joint Japan/ UK Science and Policy Workshop was hosted by the National Centre for Global Health and Medicine (NCGM) and Sir Howard Dalton Centre (HDC), and the University of Warwick. The workshop gathered stakeholders from science, policy, academia, industry, and philanthropy to address how new national and international cross-sectoral partnerships might work together in a sustainable manner for future antibiotic discovery.
Session 3 (Part 1) featured speakers on the theme of “Industry-Academia Collaboration for Sustainable Capacity Building in Antibiotic Drug Discovery – Next Generation Scientists, Lessons from Past Experiences, and Future Plans.”
The lecture concluded with a panel discussion and Q&A.
Chair
UK – Annette von Delft (Centre for Medicines Discovery, Oxford University)
Japan – Yui Kohno (Health and Global Policy Institute (HGPI))
Panelists (Speaking Order)
Dave Powell (Chief Scientific Officer, LIfeArc)
Manabu Sumi (Cabinet Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat)
Takuko Sawada (Director of the Board and Executive Vice President, Shionogi & Co.)
Munehiro Asally (Associate Professor, School of Life Sciences, University of Warwick)
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Publication Report] The Child Health Project Publishes Family Mental Health Booklet “Learning and Practicing at Home – Stress Management for Children with Intellectual Disabilities” (February 3, 2025)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”